Truphone to Lead an Invisible Revolution at Mobile World Congress 2023
22.2.2023 16:25:00 EET | Business Wire | Press release
Truphone, the pioneering global connectivity provider, today announced it will be showcasing its industry-leading innovations at the upcoming Mobile World Congress (MWC) event in Barcelona, from February 27th to March 2nd, 2023.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230222005594/en/
Truphone to Lead an Invisible Revolution at Mobile World Congress 2023 (Graphic: Business Wire)
Presenting from Booth 7B71, Hall 7, Truphone will reveal how it’s driving the “Invisible Revolution” of truly global, seamless cellular connectivity by unveiling products such as eSIM Launch Pad, its world-class Remote SIM Provisioning and Entitlements Server platform that brings even more value to its eSIM offering for mobile carriers and device makers.
They’ll also be presenting a cutting-edge demonstration of how their leadership position on the game-changing new SGP.31 eSIM Internet of Things (IoT) Architecture and Requirements Specification embodies their commitment to delivering choice and freedom. By removing operator lock-in and democratising connectivity for the entire IoT connectivity ecosystem, Truphone is paving the way for new opportunities and growth for cellular IoT technologies.
At the booth, attendees will also have the opportunity to meet with Truphone's senior team and industry experts, as well as Hakan Koç, one of Truphone’s two new co-owners, to learn more about the company's new vision and strategy.
"We’re thrilled to be exhibiting at MWC 2023 and showcasing our latest technologies to the telecommunications industry," said Harry Odenhoven, CEO of Truphone. "We believe that Truphone is at the forefront of transforming the landscape of global cellular connectivity by providing more choice and freedom than any other provider, and we’re excited to demonstrate our commitment to that by sharing our vision for the future."
With a track record of pioneering industry-firsts, Truphone has become one of the world's most respected telecommunications and connectivity companies. By leveraging its global network infrastructure and technology, Truphone is transforming the way businesses and consumers connect and communicate, delivering true mobility and flexibility to its customers.
To learn more about Truphone is driving the Invisible Revolution and helping to shape the way the world connects, visit the company at MWC 2023 at Booth 7B71, Hall 7.
About Truphone
We’re on a mission to connect the world seamlessly.
That’s why we aim to enable more connections than anyone else and why we’ve been pioneering the eSIM revolution from the very beginning.
From international enterprises and consumers to IOT device makers and Telecommunications operators, our global network and connectivity solutions enable people, devices and networks to connect anywhere, instantly, with one platform to connect billions.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230222005594/en/
Contact information
Guy Thornton
Head of Product Marketing
07702 443568
guy.thornton@truphone.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
LTM Launches BlueVerse™ for iRun to Outcreate Managed Services in the Agentic AI Era15.6.2026 09:10:00 EEST | Press release
LTM, the Business Creativity partner to the world’s largest enterprises, today announced the launch of BlueVerse™ for iRun, an AI-native managed services model designed to transform traditional IT operations into a resilient, intelligent, and outcome-driven operating model. As enterprise environments grow more complex—spanning hybrid cloud, SaaS, and AI-driven ecosystems—traditional managed services models are increasingly constrained by siloed teams, static processes, and effort-led scaling. BlueVerse for iRun addresses this shift by moving beyond headcount-based delivery to a platform-led approach powered by agentic AI, knowledge convergence, and process-as-code. Built on the BlueVerse ecosystem, iRun creates a unified intelligence layer that brings together enterprise data, telemetry, workflows, and operational context—enabling AI to reason across systems, identify root causes, and execute actions within governed guardrails. iRun combines AI agents and human expertise to shift opera
Azafaros to Present at BIO International Convention 202615.6.2026 08:00:00 EEST | Press release
Azafaros, a private company building a portfolio to become a leader in lysosomal storage disorders (LSDs), focused on addressing neurological symptoms, today announced that it will present at the 2026 BIO International Convention taking place in San Diego, USA, from June 22-25. The company’s presentation is scheduled for Monday, June 22 at 4:30 PM in Theater 4. The presentation will highlight Azafaros’ progress in developing nizubaglustat, its lead investigational compound for the treatment of rare lysosomal storage disorders with neurological involvement, including GM1 and GM2 gangliosidoses (GM1/GM2) and Niemann-Pick type C disease (NPC). Nizubaglustat is currently in two Phase 3 registrational studies (NAVIGATE) treating patients with GM1/GM2 and NPC and expects to report topline data from the studies in 2028. “BIO provides an important opportunity to update our progress as we continue advancing nizubaglustat through late-stage clinical development,” said Stefano Portolano, CEO at A
Teledyne FLIR Defense Launches Black Recon™ Autonomous Micro-Drone15.6.2026 07:05:00 EEST | Press release
Teledyne FLIR Defense, part of Teledyne Technologies Incorporated (NYSE: TDY), today announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone system that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260614388428/en/ Teledyne FLIR Defense announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. Black Recon allows crews to launch, operate, recover, and recharge up to three UAS without leaving their platform, reducing operator risk. Designed for vehicle integration, Black Recon allows crews to launch, operate, recover, and recharge up to three unmanned aerial systems without leaving their platform, reducing risk and accelerating decision-making. “Black Recon
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 11:00:00 EEST | Press release
OM Pharma will reveal preliminary results from the REACH study at the European Academy of Allergy and Clinical Immunology (EAACI) Congress. REACH is the first and largest multi-country real-world evidence (RWE) study to date evaluating the impact of Broncho-Vaxom® in patients with recurrent respiratory tract infections (RTIs).1,2 The findings offer critical new clinical evidence of the therapy's effectiveness in everyday clinical practice. In a real-world cohort of 15,794 paediatric (aged >1 year), adolescent, adult and elderly patients in China, Italy, and Belgium, Broncho-Vaxom® was associated with reductions in RTI recurrence and healthcare utilisation at 12 and 24 months after treatment initiation, compared with the 12 months prior to starting the therapy.1 “The REACH real-world evidence study shows that Broncho-Vaxom® can significantly reduce infections requiring medical visits across age groups and co-morbidities,” said Anna Thomas, Chief Scientific Officer at OM Pharma. “Recurre
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 18:15:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced updated clinical data from two Phase 1 studies evaluating the safety, tolerability and efficacy of INCA033989, a first-in-class mutant calreticulin (mutCALR)-targeted monoclonal antibody, in patients with mutCALR-expressing myeloproliferative neoplasms (MPNs). INCA033989 demonstrated rapid, clinically meaningful responses and consistent molecular activity across both myelofibrosis (MF) and essential thrombocythemia (ET), with convergent evidence supporting the potential for disease modification. These findings are being presented in oral and poster presentations at the European Hematology Association (EHA) 2026 Congress in Stockholm, Sweden (Session: Myeloproliferative neoplasms – Clinical, Presentation numbers: S216, PS1983, PF884). “The data presented at EHA 2026 demonstrate clinically meaningful and consistent responses with INCA033989 across both myelofibrosis and essential thrombocythemia,” said Pablo J. Cagnoni, M.D., President of Incyte and G
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom